Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy

Development of cardiac hypertrophy and progression to heart failure entails profound changes in myocardial metabolism, characterized by a switch from fatty acid utilization to glycolysis and lipid accumulation. We report that hypoxia-inducible factor (HIF)1alpha and PPARgamma, key mediators of glyco...

Full description

Saved in:
Bibliographic Details
Published in:Cell metabolism 2009-06, Vol.9 (6), p.512-524
Main Authors: Krishnan, Jaya, Suter, Marianne, Windak, Renata, Krebs, Tatiana, Felley, Allison, Montessuit, Christophe, Tokarska-Schlattner, Malgorzata, Aasum, Ellen, Bogdanova, Anna, Perriard, Evelyne, Perriard, Jean-Claude, Larsen, Terje, Pedrazzini, Thierry, Krek, Wilhelm
Format: Article
Language:English
Subjects:
Animals
Apoptosis
Cardiomegaly - metabolism
Fatty Acids - metabolism
Glycolysis
Hypoxia-Inducible Factor 1, alpha Subunit - genetics
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Lipid Metabolism
Mice
Mice, Knockout
Myocytes, Cardiac - metabolism
Phosphoric Monoester Hydrolases - metabolism
PPAR gamma - genetics
PPAR gamma - metabolism
Up-Regulation
Von Hippel-Lindau Tumor Suppressor Protein - metabolism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Development of cardiac hypertrophy and progression to heart failure entails profound changes in myocardial metabolism, characterized by a switch from fatty acid utilization to glycolysis and lipid accumulation. We report that hypoxia-inducible factor (HIF)1alpha and PPARgamma, key mediators of glycolysis and lipid anabolism, respectively, are jointly upregulated in hypertrophic cardiomyopathy and cooperate to mediate key changes in cardiac metabolism. In response to pathologic stress, HIF1alpha activates glycolytic genes and PPARgamma, whose product, in turn, activates fatty acid uptake and glycerolipid biosynthesis genes. These changes result in increased glycolytic flux and glucose-to-lipid conversion via the glycerol-3-phosphate pathway, apoptosis, and contractile dysfunction. Ventricular deletion of Hif1alpha in mice prevents hypertrophy-induced PPARgamma activation, the consequent metabolic reprogramming, and contractile dysfunction. We propose a model in which activation of the HIF1alpha-PPARgamma axis by pathologic stress underlies key changes in cell metabolism that are characteristic of and contribute to common forms of heart disease.
ISSN:1932-7420
DOI:10.1016/j.cmet.2009.05.005